Home Healthcare Healthcare IT Digital Biomarkers Market

Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Data Collection Tools, Data Integration Tools), By Clinical Practice (Diagnostic, Monitoring, Prognostic, Predictive, Others), By Therapeutic Area (Cardiovascular and Metabolic Disorders, Respiratory Disorders, Neurological Disorders, Musculoskeletal Disorders, Psychiatric Disorders, Other Applications), By End-User (Pharmaceutical Companies, Healthcare Providers, Payers, Other End-Users) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Digital Biomarkers Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Data Collection Tools
    2. Data Integration Tools
  2. Digital Biomarkers Market, By Clinical Practice 2022-2034 (USD MILLION/ Units)
    1. Diagnostic
    2. Monitoring
    3. Prognostic
    4. Predictive
    5. Others
  3. Digital Biomarkers Market, By Therapeutic Area 2022-2034 (USD MILLION/ Units)
    1. Cardiovascular and Metabolic Disorders
    2. Respiratory Disorders
    3. Neurological Disorders
    4. Musculoskeletal Disorders
    5. Psychiatric Disorders
    6. Other Applications
  4. Digital Biomarkers Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical Companies
    2. Healthcare Providers
    3. Payers
    4. Other End-Users
  5. Regional Digital Biomarkers Market
    1. North America
      1. North America Digital Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Data Collection Tools
        2. Data Integration Tools
      2. North America Digital Biomarkers Market By Clinical Practice 2022-2034 (USD MILLION/ Units)
        1. Diagnostic
        2. Monitoring
        3. Prognostic
        4. Predictive
        5. Others
      3. North America Digital Biomarkers Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Cardiovascular and Metabolic Disorders
        2. Respiratory Disorders
        3. Neurological Disorders
        4. Musculoskeletal Disorders
        5. Psychiatric Disorders
        6. Other Applications
      4. North America Digital Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
        2. Healthcare Providers
        3. Payers
        4. Other End-Users
      5. U.S.
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      6. Canada
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
    2. Europe
      1. Europe Digital Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Data Collection Tools
        2. Data Integration Tools
      2. Europe Digital Biomarkers Market By Clinical Practice 2022-2034 (USD MILLION/ Units)
        1. Diagnostic
        2. Monitoring
        3. Prognostic
        4. Predictive
        5. Others
      3. Europe Digital Biomarkers Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Cardiovascular and Metabolic Disorders
        2. Respiratory Disorders
        3. Neurological Disorders
        4. Musculoskeletal Disorders
        5. Psychiatric Disorders
        6. Other Applications
      4. Europe Digital Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
        2. Healthcare Providers
        3. Payers
        4. Other End-Users
      5. U.K.
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      6. Germany
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      7. France
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      8. Spain
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      9. Italy
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      10. Russia
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      11. Nordic
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      12. Benelux
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      13. Rest of Europe
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
    3. APAC
      1. APAC Digital Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Data Collection Tools
        2. Data Integration Tools
      2. APAC Digital Biomarkers Market By Clinical Practice 2022-2034 (USD MILLION/ Units)
        1. Diagnostic
        2. Monitoring
        3. Prognostic
        4. Predictive
        5. Others
      3. APAC Digital Biomarkers Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Cardiovascular and Metabolic Disorders
        2. Respiratory Disorders
        3. Neurological Disorders
        4. Musculoskeletal Disorders
        5. Psychiatric Disorders
        6. Other Applications
      4. APAC Digital Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
        2. Healthcare Providers
        3. Payers
        4. Other End-Users
      5. China
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      6. Korea
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      7. Japan
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      8. India
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      9. Australia
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      10. Singapore
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      11. Taiwan
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      12. South East Asia
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      13. Rest of Asia-Pacific
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
    4. Middle East and Africa
      1. Middle East and Africa Digital Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Data Collection Tools
        2. Data Integration Tools
      2. Middle East and Africa Digital Biomarkers Market By Clinical Practice 2022-2034 (USD MILLION/ Units)
        1. Diagnostic
        2. Monitoring
        3. Prognostic
        4. Predictive
        5. Others
      3. Middle East and Africa Digital Biomarkers Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Cardiovascular and Metabolic Disorders
        2. Respiratory Disorders
        3. Neurological Disorders
        4. Musculoskeletal Disorders
        5. Psychiatric Disorders
        6. Other Applications
      4. Middle East and Africa Digital Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
        2. Healthcare Providers
        3. Payers
        4. Other End-Users
      5. UAE
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      6. Turkey
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      7. Saudi Arabia
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      8. South Africa
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      9. Egypt
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      10. Nigeria
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      11. Rest of MEA
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
    5. LATAM
      1. LATAM Digital Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Data Collection Tools
        2. Data Integration Tools
      2. LATAM Digital Biomarkers Market By Clinical Practice 2022-2034 (USD MILLION/ Units)
        1. Diagnostic
        2. Monitoring
        3. Prognostic
        4. Predictive
        5. Others
      3. LATAM Digital Biomarkers Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Cardiovascular and Metabolic Disorders
        2. Respiratory Disorders
        3. Neurological Disorders
        4. Musculoskeletal Disorders
        5. Psychiatric Disorders
        6. Other Applications
      4. LATAM Digital Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
        2. Healthcare Providers
        3. Payers
        4. Other End-Users
      5. Brazil
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      6. Mexico
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      7. Argentina
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      8. Chile
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      9. Colombia
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
      10. Rest of LATAM
        1. Data Collection Tools
        2. Data Integration Tools
        3. Diagnostic
        4. Monitoring
        5. Prognostic
        6. Predictive
        7. Others
        8. Cardiovascular and Metabolic Disorders
        9. Respiratory Disorders
        10. Neurological Disorders
        11. Musculoskeletal Disorders
        12. Psychiatric Disorders
        13. Other Applications
        14. Pharmaceutical Companies
        15. Healthcare Providers
        16. Payers
        17. Other End-Users
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.